🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mark A. Socinski

Florida Hospital Cancer Institute

ORCID: 0000-0003-2915-9325

Also affiliated with AdventHealth Tampa

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.634Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2323
Top 31%
0.634DataRank
Top 31%20 citations

Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou +10 more

Papers

Driven by 7 papers — median percentile 69. Top paper: “Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types”.

Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types

Clinical Cancer Research(2010)10.1158/1078-0432.ccr-10-0199
N/A
0.853DataRank · unranked
294 citations

Xiaoying Yin, Katherine A. Hoadley, Yufeng Liu, Michele C. Hayward, Christopher R. Cabanski +15 more

Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2323
Top 31%
0.634DataRank
Top 31%20 citations

Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou +10 more

Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity

Nature Communications(2025)10.1038/s41467-025-61817-8
N/A
0.345DataRank · unranked
9 citations

Jacqulyne Robichaux, Monique B. Nilsson, R. S. K. Vijayan, Ashwin Ravichandran, Jia Wu +21 more

Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9544
N/A
0.269DataRank · unranked
5 citations

Ari M. Vanderwalde, Hirva Mamdani, Luis E. Raez, Yasmine Baca, Joanne Xiu +14 more

Erlotinib in African Americans With Advanced Non–Small Cell Lung Cancer: A Prospective Randomized Study With Genetic and Pharmacokinetic Analyses

UNC Libraries(2020)10.17615/05ak-3t14
N/A
0DataRank · unranked
0 citations

You-Han Gao, L. Wei, J. Li, D. Wang, Mark A. Socinski +12 more

Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types

UNC Libraries(2020)10.17615/5tdz-sn55
N/A
0DataRank · unranked
0 citations

Philip S. Bernard, Alden M. Parsons, Kenneth L. Muldrew, Leigh B. Thorne, Mark A. Socinski +13 more

Differential Pathogenesis of Lung Adenocarcinoma Subtypes Involving Sequence Mutations, Copy Number, Chromosomal Instability, and Methylation

UNC Libraries(2020)10.17615/0bw4-4n26
N/A
0DataRank · unranked
0 citations

Alden M. Parsons, Philip S. Bernard, Leigh B. Thorne, C. Ryan Miller, William K. Funkhouser +12 more